# Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder

> **NCT00694798** · PHASE1 · COMPLETED · sponsor: **Cadila Pharnmaceuticals** · enrollment: 22 (actual)

## Conditions studied

- Bladder Cancer

## Interventions

- **BIOLOGICAL:** Mycobacterium w

## Key facts

- **NCT ID:** NCT00694798
- **Lead sponsor:** Cadila Pharnmaceuticals
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-10
- **Primary completion:** 2011-07
- **Final completion:** 2011-07
- **Target enrollment:** 22 (ACTUAL)
- **Last updated:** 2012-05-03


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00694798

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00694798, "Study of Mycobacterium w in BCG Refractory Superficial Transitional Cell Carcinoma of Bladder". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00694798. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*